Closure of Patent Foramen Ovale or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00562289

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:46.676988+00:00

Published At

2017-10-19T00:00:00+00:00

Record Updated At

2017-10-19

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Ischemic Stroke", "Patent Foramen Ovale", "Atrial Septal Aneurysm", "Migraine"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2017-10-19"

protocolSection.identificationModule.nctId

"NCT00562289"

protocolSection.identificationModule.officialTitle

"Closure of Patent Foramen Ovale or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Ischemic Stroke (protocolSection.conditionsModule.conditions)
• Patent Foramen Ovale (protocolSection.conditionsModule.conditions)
• Atrial Septal Aneurysm (protocolSection.conditionsModule.conditions)
• Migraine (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.